CHICAGO—Although nearly nine in 10 transthoracic echocardiograms (TTEs) met appropriate use criteria (AUC) by 2011, fewer than one-third resulted in a change in care, according to a single-center study presented March 26 as a scientific poster at the 61st annual American College of Cardiology (ACC) scientific session.
When it comes to cost effectiveness, echocardiography and chronic coronary artery disease (CAD), consider rethinking the terminology. That was one message from a March 25 presentation at the American College of Cardiology’s (ACC) 61st annual scientific session.
The International Contrast Ultrasound Society (ICUS) has applauded the FDA’s decision to modify the U.S. product label for Definity Injectable Suspension, an ultrasound contrast agent.
The early measurement of coronary flow reserve (CRF) by transthoracic Doppler echocardiography can be of high value for the assessment of successful reperfusion in acute MI and can be used to predict left ventricular functional recovery, myocardial viability and the final infarct size, according to a study published online May 28 in Cardiovascular Ultrasound.
RSS 
